We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current CSWYF market cap is 830.31M. The company's latest EPS is CNY 1.1723 and P/E is 0.85.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Revenue | 2.71B | 2.66B | 3.22B | 3.95B | 4.52B |
| Operating Income | 526.48M | 285.77M | 643.61M | 835.77M | 1.14B |
| Net Income | 503.15M | 295.03M | 556.67M | 722.77M | 969.51M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Assets | 7.13B | 7.21B | 7.2B | 8.23B | 9.57B |
| Total Liabilities | 1.35B | 1.42B | 1.3B | 1.85B | 2.54B |
| Total Equity | 5.78B | 5.79B | 5.9B | 6.38B | 7.03B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Operating | 368M | 638.57M | 703.15M | 1.11B | 932.64M |
| Investing | 69.54M | -305.59M | 395.01M | -45.42M | -49.54M |
| Financing | -100.69M | -329.79M | -828.94M | -250.04M | -26.74M |
| Market Cap | 830.31M |
| Price to Earnings Ratio | 0.85 |
| Price to Sales Ratio | 0.18 |
| Price to Cash Ratio | 0.14 |
| Price to Book Ratio | 0.12 |
| Dividend Yield | - |
| Shares Outstanding | 827M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 200 |
| 52 Week Change | -7.04% |
| 52 Week High | 1.08 |
| 52 Week Low | 0.9253 |
| Spread (Intraday) | 0.81 (57.04%) |
| Company Name | China Shineway Pharmaceutical Group Limited (PK) |
| Address |
cricket square grand cayman KY1-1111 |
| Website | https://www.shineway.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
